This project was also supported by the Medical Research Council (MR/R010676/1, MR/N00275X/1 and MR/S025618/1, and MR/N020081/1), the European Federation for the Study of Diabetes, Diabetes UK (including grant 17/0005681), the Academy of Medical Sciences, Society for Endocrinology, The British Society for Neuroendocrinology, the Engineering and Physical Sciences Research Council, the European Research Council under the European Unions Horizon 2020 research and innovation programme (Starting Grant 715884), UKRI Future Leaders Fellowship (MR/S031537/1), Fondation de la Recherche Mdicale (Equipe FRM DEQ20130326503, EQU201903008055), Agence Nationale de la Recherche (ANR-19-CE16-0025-01, ANR-15-CE14-0025-02), Institut National de la Sant et de la Recherche Mdicale (INSERM), and Centre National de la Recherche Scientifique (CNRS)
NICE guidance (CG189) indicates that a realistic and healthy rate of weight loss is approximately 0.5 to 1 kg per week
Dietary fiber-induced microbial short chain fatty acids suppress ILC2-dependent airway inflammation
By activating both GIP and GLP-1 receptors, Mounjaro exerts a multifaceted impact on the body, contributing to weight loss through several mechanisms
"Transport of glutamate and other amino acids at the bloodbrain barrier"
